title: Identification of fumonisin B1 as an inhibitor of argininosuccinate synthetase using fumonisin affinity chromatography and in vitro kinetic studies.
abstract: Fumonisin B1, a fungal mycotoxin that grows on corn and other agricultural products, alters sphingolipid metabolism by inhibiting ceramide synthase. The precise mechanism of fumonisin B1 toxicity has not been completely elucidated; however, a central feature in the cytotoxicity is alteration of sphingolipid metabolism through interruption of de novo ceramide synthesis. An affinity column consisting of fumonisin B1 covalently bound to an HPLC column matrix was used to isolate a rat liver protein that consistently bound to the column. The protein was identified as argininosuccinate synthetase by protein sequencing. The enzyme-catalyzed formation of argininosuccinic acid from citrulline and aspartate by recombinant human and rat liver argininosuccinate synthetase was inhibited by fumonisin B1. Fumonisin B1 showed mixed inhibition against citrulline, aspartate, and ATP to the enzyme. Fumonisin B1 had a Ki' of approximately 6 mM with the recombinant human argininosuccinate synthase and a Ki' of 35 mM with a crude preparation of enzyme prepared from rat liver. Neither tricarballylic acid nor hydrolyzed fumonisin B1 inhibited recombinant human argininosuccinate synthetase. This is the first demonstration of fumonisin B1 inhibition of argininosuccinate synthethase, a urea cycle enzyme, which adds to the list of enzymes that are inhibited in vitro by fumonisin B1 (ceramide synthase, protein serine/threonine phosphatase). The extent of the inhibition of argininosuccinate synthetase in cells, and the possible role of this enzyme inhibition in the cellular toxicity of FB1, remains to be established.
authors.affiliation: Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR 72079-9205, USA.
authors.forename: G R
authors.initials: GR
authors.lastname: Jenkins
authors.forename: W H
authors.initials: WH
authors.lastname: Tolleson
authors.forename: D K
authors.initials: DK
authors.lastname: Newkirk
authors.forename: D W
authors.initials: DW
authors.lastname: Roberts
authors.forename: K L
authors.initials: KL
authors.lastname: Rowland
authors.forename: T
authors.initials: T
authors.lastname: Saheki
authors.forename: K
authors.initials: K
authors.lastname: Kobayashi
authors.forename: P C
authors.initials: PC
authors.lastname: Howard
authors.forename: W B
authors.initials: WB
authors.lastname: Melchior
mesh_terms: D000818:Animals; D001124:Argininosuccinate Synthase / Q000037:antagonists & inhibitors*; D002264:Carboxylic Acids / Q000494:pharmacology*; D002846:Chromatography, Affinity / Q000379:methods; D002851:Chromatography, High Pressure Liquid; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D037341:Fumonisins; D006801:Humans; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D008297:Male; D011485:Protein Binding; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors
chemical_list: D002264:Carboxylic Acids; D004791:Enzyme Inhibitors; D037341:Fumonisins; D011994:Recombinant Proteins; C056933:fumonisin B1; D001124:Argininosuccinate Synthase